ArticleBMC infectious diseases2018
Assessment of the societal cost of Taenia solium in Angónia district, Mozambique.
Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 34 citations in OpenAlex.
- Prevalence of neurocysticercosis and its characteristics among people with epileptic seizures and progressively worsening severe headaches in 60 villages in three provinces of Burkina Faso.PLoS neglected tropical diseases · 2026Trial
- Spatial and temporal risk mapping of human and porcine Taenia solium infections in Malawi: a systematic review and geostatistical approach.One health outlook · 2026Article
- Why are toilets not used? Using system effects modelling to understand stakeholder perceptions on the impacts and barriers to Taenia solium control in Eastern and Western Uganda.BMC veterinary research · 2025Article
- Seroprevalence and risk factors of porcine cysticercosis in Mpwapwa district, eastern-Central Tanzania.Parasite epidemiology and control · 2025Article
- Baseline Assessment of Taeniasis and Cysticercosis Infections in a High-Priority Region forPathogens (Basel, Switzerland) · 2025Article
- Article
- Insights into the diagnosis, vaccines, and control of Taenia solium, a zoonotic, neglected parasite.Parasites & vectors · 2023Review
- Monetary burden of neurocysticercosis on a hospitalized population in Muli County, China.Acta tropica · 2023Article
- Approaches for disease prioritization and decision-making in animal health, 2000-2021: a structured scoping review.Frontiers in veterinary science · 2023Article
- Assessing the burden of Taenia solium cysticercosis in Burundi, 2020.BMC infectious diseases · 2022Article
- A scoping review of burden of disease studies estimating disability-adjusted life years due to Taenia solium.PLoS neglected tropical diseases · 2022Article
- Prevalence and molecular characterization of cystic hydatidosis in livestock slaughtered in southern Mozambique.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022Article
- Seroprevalence and risk factors of porcine cysticercosis: A cross-sectional study in Indonesia.Veterinary world · 2022Article
- Challenges in the Diagnosis ofVeterinary medicine international · 2022Article
- Effects of 'The Vicious Worm' educational software on Taenia solium knowledge among key pork supply chain workers in Zambia.PLoS neglected tropical diseases · 2020Article
- Modelling forBulletin of the World Health Organization · 2020Article
- The World Health Organization 2030 goals forGates open research · 2019Article
- Factors Associated with the 18-Month Cumulative Incidence of Seroconversion of Active Infection withThe American journal of tropical medicine and hygiene · 2018Article
- Spatial distribution of Taenia solium exposure in humans and pigs in the Central Highlands of Vietnam.PLoS neglected tropical diseases · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 4 countries.
Funding
Abstract
backgroundThe zoonotic parasite Taenia solium is endemic in Angónia district, Tete province, Mozambique, though the burden of the disease complex is unknown.
methodsAs part of two cross-sectional studies on human and porcine cysticercosis in the area, unique epidemiological and cost data were collected in Angónia district, Mozambique in 2007. These data provided the basis for the assessment of the societal cost of T. solium in the district, which estimates the impact of the disease on human and pig populations and includes both health and economic approaches in the analysis.
resultsApproximately 0.7% (95% Uncertainty Interval (UI), 0.4-0.9) and 0.4% (95% UI, 0.2-0.6) of the total population in the district was estimated to suffer from neurocysticercosis (NCC)-associated epilepsy and headache. The estimated average number of disability-adjusted life years (DALYs) due to NCC-associated epilepsy and headache was 6 (95% UI, 4-8) per thousand persons per year. The total annual costs due to T. solium cysticercosis were estimated at 90,000 USD (95% UI, 39,483-201,463) of which 72% (95% UI, 45-91) were costs linked to human cysticercosis and 28% (95% UI, 9.5-55) to pig production losses. The annual economic burden per NCC-associated epilepsy case in the district amounted to 33 USD (95% UI, 10-76).
conclusionsIn this highly endemic area of Mozambique a large number of individuals suffer from symptoms associated with NCC. Healthy years of life are lost and people are left living with disabilities. Infected pork poses a serious risk to the community and affects the economy of smallholder farmers. Cost for treatment and hospitalization of patients with NCC-associated epilepsy, and lack of productivity and inability of suffering patients to work, further hinder socioeconomic development. Feasible solutions framed within a country specific algorithm and stepwise approaches are needed to control the parasite in the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.